Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has shared an update.
WuXi AppTec plans to amend its 2025 H Share Award and Trust Scheme so that awards can also be satisfied with Treasury H Shares, in addition to H shares acquired on market, effectively turning the plan into a share scheme that can involve the grant or transfer of new company shares under Hong Kong’s Chapter 17 requirements. The proposed changes introduce a scheme mandate limit and refresh mechanism, an individual grant cap with independent shareholder approval for any excess, enhanced approval rules for awards to directors and major shareholders, a 12‑month minimum vesting period with limited exceptions, and a requirement for shareholder approval of key rule alterations, thereby tightening governance and aligning the scheme with updated listing standards and the company’s fund management needs.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$124.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-based life sciences and pharmaceutical services company whose H shares are listed in Hong Kong, and it operates share award and trust schemes using H shares to incentivize and retain participants in line with Hong Kong listing rules and corporate governance standards.
Average Trading Volume: 4,883,675
Technical Sentiment Signal: Buy
Current Market Cap: HK$303.7B
Learn more about 2359 stock on TipRanks’ Stock Analysis page.